The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis.
Sci Transl Med. 2017 May 24;9(391):eaaf3962. doi: 10.1126/scitranslmed.aaf3962.
Sci Transl Med. 2017.
PMID: 28539470
Free article.